The Prostate, Lung, Colorectal and Ovarian Screening Study randomised over 76 000 men to annual PSA screening or usual care.2 It showed no difference in prostate cancer mortality in the screened and control arms but has been criticised because half of the control arm had a PSA test during the study. This evidence concerns the gene KLK3 and prostate carcinoma.